Pro-Dex Inc
$ 56.01
2.47%
21 Jul - close price
- Market Cap 174,516,000 USD
- Current Price $ 56.01
- High / Low $ 56.70 / 54.12
- Stock P/E 15.75
- Book Value 14.14
- EPS 3.47
- Next Earning Report 2026-09-03
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.10 %
- ROE 0.30 %
- 52 Week High 68.99
- 52 Week Low 23.47
About
Pro-Dex, Inc. designs, develops and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company is headquartered in Irvine, California.
Analyst Target Price
$70.00
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-30 | 2026-01-29 | 2025-10-30 | 2025-09-04 | 2025-05-01 | 2025-01-30 | 2024-10-31 | 2024-09-05 | 2024-05-02 | 2024-02-08 | 2023-10-13 | 2023-09-29 |
| Reported EPS | 1.2 | 0.6619 | 1.4 | 0.36 | 0.85 | 0.61 | 0.75 | 0.46 | 0.19 | 0.14 | -0.17 | 0.42 |
| Estimated EPS | 0.62 | 0.59 | 0.5 | 0.47 | 0.47 | 0.38 | 0.29 | 0.35 | 0.35 | 0.35 | 0.32 | 0.33 |
| Surprise | 0.58 | 0.0719 | 0.9 | -0.11 | 0.38 | 0.23 | 0.46 | 0.11 | -0.16 | -0.21 | -0.49 | 0.09 |
| Surprise Percentage | 93.5484% | 12.1864% | 180% | -23.4043% | 80.8511% | 60.5263% | 158.6207% | 31.4286% | -45.7143% | -60% | -153.125% | 27.2727% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-09-03 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.67 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PDEX
2026-07-15 21:40:35
Angelita Rebamontan Domingo, a director at PRO DEX INC (NASDAQ:PDEX), recently sold 998 shares of the company's common stock for $47.24 per share, totaling $47,145. Following the transaction, Domingo directly holds 18,779 shares, and the stock has since climbed 23%. The company's stock is currently on InvestingPro's Most Overvalued list, though it maintains a "GREAT" financial health score and trades at a PEG ratio of 0.53.
2026-07-14 21:44:55
Angelita Rebamontan Domingo, a director at PRO DEX INC (NASDAQ: PDEX), recently sold 998 shares of the company's common stock for $47,145. The transaction occurred on March 16, 2026, at $47.24 per share. Following the sale, Domingo directly holds 18,779 shares, and the stock has since increased by 23% to $58.26, while analysts consider it overvalued despite a "GREAT" financial health score and an attractive PEG ratio of 0.53.
2026-07-14 21:44:55
This article from Investing.com announces the filing of Form 4 for Pro-Dex Inc. on July 14. The concise piece indicates a financial disclosure but provides no further details on the content of the form. It notes the stock symbol PDEX is down 5.35%.
2026-07-14 21:44:55
A director at Pro-Dex Inc. (NASDAQ: PDEX), Domingo Angelita Rebamontan, sold 998 shares of common stock in an open-market transaction on March 16, 2026, at a price of $47.24 per share. Following this sale, the director directly holds 18,779 shares of Pro-Dex common stock. The transaction, categorized as a net sell of $47,146, was reported in a Form 4 SEC filing.
2026-07-02 05:09:13
This article provides current stock information for Pro-Dex Inc New (PDEX), including its latest trading price of $62.03, recent performance, and key market data. It also details the company's business activities as a designer and manufacturer of powered surgical instruments and provides a guide on how to buy PDEX stock on MEXC. The FAQ section offers further insights into its market classification, financial metrics, and dividend policy.
2026-06-30 18:42:06
This article reports on the filing of Form 13D/A for PRO-DEX as of June 26, 2026. Form 13D/A is an amendment to a Schedule 13D, primarily filed by an investor who acquires more than 5% of a company's stock, indicating significant ownership and potential influence. The brief entry provides the stock symbol PDEX and its performance for the given date.
